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Abstract
Prevalence and predictors of transmitted drug resistance (TDR), defined as the presence of at least one WHO surveillance drug resistance
mutation (SDRM), were investigated in antiretroviral-naı¨ve HIV-1-infected patients, with a genotypic resistance test (GRT) performed
£6 months before starting cART between 2000 and 2010. 3163 HIV-1 sequences were selected (69% subtype B). Overall, the prevalence
of TDR was 12% (13.2% subtype B, 9% non-B). TDR significantly declined overall and for the single drug classes. Older age independently
predicted increased odds of TDR, whereas a more recent GRT, a higher HIV-RNA and C vs. B subtype predicted lower odds of TDR.
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Abstract
The occurrence and clinical impact of herpes simplex virus (HSV) were evaluated in 342 bronchoalveolar lavage specimens from 237
patients. HSV-1 and HSV-2 were detected in 32.1% and <1% of patients, respectively. A significant difference of HSV-1 prevalence and load
was found in relation to admission to intensive care unit, mechanical ventilation and mortality within 28 days; in particular, a viral load ‡105
copies/mL bronchoalveolar lavage fluid was significantly associated with critical features. No association was found with immune status or
other characteristics. Nine of 21 (42.9%) cases of ventilator-associated pneumonia were positive for HSV-1, with poor outcome in six.
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